Travere Therapeutics Inc

NASDAQ:TVTX   3:59:51 PM EDT
26.54
+0.26 (+0.99%)
Products, Strategic Combinations

Vifor Pharma And Travere Therapeutics Announce Licensing Agreement For Sparsentan

Published: 09/16/2021 05:16 GMT
Travere Therapeutics Inc (TVTX) - Vifor Pharma and Travere Therapeutics Announce Licensing Agreement for Commercialization of Sparsentan in Europe, Australia and New Zealand.
Travere Receives a USD 55 Million Upfront Payment and is Eligible for Additional Regulatory and Commercial Milestones, As Well As Tiered Royalties on Net Sales.